1 Marine Bioresources Research Group, Field Science Center for Northern Biosphere, Hokkaido University, Hakodate 041-8611, Japan
2 Division of Marine Biosciences, Graduate School of Fisheries Science, Hokkaido University, Hakodate 041-8611, Japan
*Author for correspondence (e-mail: takeshi{at}fish.hokudai.ac.jp)
Accepted 14 March 2002
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Spermatogenesis-preventing substance, Müllerian inhibiting substance, Gene expression screening, In vitro spermatogenesis, Eel
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Various reproductive styles and gametogenetic patterns exist among species of teleost. Japanese eel, for example, has a specific spermatogenetic pattern. Under fresh-water culture conditions, the male Japanese eel has immature testes containing only non-proliferated type A and early type B spermatogonia (Miura et al., 1991a). It has been reported, however, that human chorionic gonadotropin (hCG) injection can induce all stages of spermatogenesis in vivo (Miura et al., 1991a
). Furthermore, Japanese eel is the only animal in which complete spermatogenesis has been induced by hormonal treatment in vitro using an organ culture system and a germ cell/somatic cell co-culture system (Miura et al., 1991b
; Miura et al., 1991c
; Miura et al., 1996
). Thus, the eel testis provides an excellent system for studying the regulation of spermatogenesis.
Using these in vivo and in vitro systems in the eel, the following control mechanisms of spermatogenesis have been identified. The hormonal induction of spermatogenesis in eel testes is mediated via gonadotropin stimulation of Leydig cells, which produce 11-ketotestosterone (Miura et al., 1991a; Miura et al., 1991b
). In turn, 11-ketotestosterone induces complete spermatogenesis from spermatogonia to spermatozoa through the action of Sertoli cells (Miura et al., 1991c
). However, many details of this pathway remain unresolved. In particular, it seems that there are complex control mechanisms related to the initiation of spermatogenesis after 11-ketotestosterone stimulation.
It seems likely that key factors involved in the initiation of spermatogenesis are either expressed or suppressed by 11-ketotestosterone during hCG-induced spermatogenesis. Specifically, suppressive factors might have an inhibitory effect on the progress of spermatogenesis in cultivated eel. In this paper, we describe the isolation of a cDNA that is downregulated by hCG stimulation and investigate its function in initiating spermatogenesis.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Male eels were kept in 500 l circulating fresh-water tanks at 23°C. A single injection of human chorionic gonadotropin (hCG) dissolved in saline (150 mM NaCl) was administered to the eels intramuscularly at a dose of 5 IU per body weight. Fish were either sacrificed immediately or at 1, 3, 6, 9, 12, 15 and 18 days after hCG injection, and testes were collected for the extraction of poly(A)+ RNA, in situ hybridisation, immunohistochemistry and western blotting. Poly(A)+ RNA was extracted using a Fast Track kit (Invitrogen).
Construction of a subtractive cDNA library
Subtractive cDNA libraries were constructed using poly(A)+ RNA extracted from the testes of hCG-treated (3 days after hCG injection) (+) and untreated () eels. First strand of cDNA was synthesised with reverse transcriptase from 5 µg of each poly(A)+ RNA using an oligo (dT) primer. The second strand of cDNA was synthesised with RNase H and E. coli DNA polymerase and repaired with bacteriophage T4 polynucleotide kinase and E. coli DNA ligase. After digestion with MboI, these cDNA fragments were subtracted from each other by a representational difference analysis (RDA) technique (Niwa et al., 1997). After three cycles of subtractive enrichment, enriched upregulated (+) and downregulated () cDNA fragments were packaged into
zap II phage particles.
We predicted that the subtracted cDNA libraries would not include full-length cDNA clones, owing to digestion of the cDNA fragments by MboI. To obtain full-length cDNA clones, therefore, we constructed in conventional cDNA libraries, using the same poly(A)+ RNA as used for cDNA subtraction, that contained full-length cDNA clones. Non-digested cDNA was size-fractionated on a Sepharose CL4B column with a lower cutoff value of 500 bp and inserted into zap II arms after the addition of EcoRI adapters.
Screening and cloning
Enriched (+) and () cDNAs were labelled using the Klenow fragment of E. coli DNA polymerase I and linker primer with [-32P]dCTP. About 104 plaques from each subtractive library were blotted onto two nylon membranes (High Bond N+: Amersham). To duplicate copies of the library, the radiolabelled (+) and () cDNA probes were hybridised separately for 18 hours at 65°C in hybridisation solution [5xDenharts solution supplement with 6xstandard sodium citrate (SSC), 0.1% sodium dodecylsulfate (SDS) and 100 µg/ml denatured, fragmented herring sperm DNA]. The clones that hybridised to () cDNA probe only were collected and purified, and plasmids were excision-rescued according to the manufacturers instructions (Stratagene).
These partial cDNA fragments were labelled using the Random Primer Plus Extension Kit (NEN) with [-32P]dCTP. About 105 plaques from intact cDNA libraries were blotted onto nylon membranes and hybridised with 1x107 cpm of the probes for 18 hours at 65°C. These membranes were washed twice with 1xSSC/1%(w/v) SDS at 65°C for 1 hour.
The cDNA inserts from positively hybridised clones were collected and purified, and plasmids were excision-rescued as above. Sequence determination was performed on a ABI PRISM 310 DNA sequencer using the BigDye Terminator Cycle Sequencing FS Ready Reaction Kit (Applied Biosystems). Sequence analysis and comparison were carried out using DNASIS software (Hitachi). The similarity search of the deduced amino acid sequence of the obtained cDNAs was done using the Fasta Sequence Similarity Search protein query (Genome Net).
Northern blot analysis
Poly(A)+ RNA (1 µg) was electrophoresed on a 1% (w/v) agarose denatured gel and blotted onto nylon membranes. The membrane was washed briefly and then baked at 80°C for 1 hour. RNA integrity, as well as uniformity of loading and transfer, was monitored by Methylene Blue staining (Herrin and Schmidt, 1988) and hybridisation to an eel elongation factor I cDNA. The cDNA fragments used as probes were labelled by the Random Primer Plus Extension labelling kit (NEN) with [
-32P]dCTP. The membrane containing poly(A)+ RNA was hybridised with 1x106 cpm of the radiolabelled probe in hybridisation solution at 65°C for 18 hours, and was then washed with 1xSSC/0.01% SDS solution at 65°C for 1 hour. The membrane was exposed to an imaging plate for 24 hours and analysed using an image analyser (Fuji Photo Film, Japan).
In situ hybridisation
For in situ hybridisation, a non-radioactive method using a digoxigenin (DIG)-labelled RNA probe was employed. A 296 bp cDNA of esrs21-0392 (nucleotides 147443 in esrs21c19) was subcloned into pBluescript II KS. Sense and antisense RNA probes were transcribed in vitro using digoxigenin-labelled UTP (Boehringer Mannheim) and T3 or T7 RNA polymerase (Gibco BRL). The testicular fragments from hCG-untreated eel were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.2) at 4°C for 18 hours, embedded in paraffin wax and cut into 5 µm serial sections. Deparaffinized sections were treated with proteinase K and acetylated. The sections were incubated with a hybridisation mixture of 200 µg/ml tRNA, 10 mM Tris-HCl (pH 7.4), 1xDenhardts solution, 600 mM NaCl, 50% formamide, 0.25% SDS and 500 ng/ml probe. After hybridisation at 50°C for 18 hours, the sections were processed as follows: (1) 2xSSC/50% formamide at 50°C for 30 minutes; (2) 2xSSC at 50°C for 30 minutes; (3) RNase A treatment (5 µg/ml) at 45°C for 30 minutes; (4) 2xSSC at 50°C for 20 minutes twice; and (5) 0.2xSSC at 50°C for 20 minutes twice. Hybridised DIG-labelled probes were immunologically detected with a Nucleic Acid Detection kit (Boehringer Mannheim) according to the manufacturers instructions. The sections were incubated with the Fab fragment of an anti-DIG-alkaline phosphatase-conjugated antibody (Boehringer Mannheim). After the nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate colour reaction, the slides were rinsed with 10 mM Tris-HCl (pH 8.0) containing 1 mM ethylenediamine tetraacetic acid (EDTA) and then stained nuclei by 0.2% Methyl Green, metachromatically. After counterstaining, the slides were mounted with cover glass.
Production of polyclonal antibody
A PCR product encoding amino acids 1-243 of eSRS21 was inserted in the EcoRI site of the pGEX-2TK vector (Pharmacia), in frame with the glutathione S-transferase gene. Host bacteria carrying the recombinant constructs were grown at 37°C until log phase and induced with 1 mM IPTG to express the fusion proteins. After a 4 hour induction period, bacteria were harvested by BugBuster protein extraction reagent (Novagen). Recombinant protein purification was performed using glutathione sepharose 4B according to the manufacturers instructions (Pharmacia). Female rabbits were immunised with 1 ml of PBS, 0.1% SDS (pH 7.5) containing 1 mg of the purified recombinant protein mixed with an equal volume of Freunds complete adjuvant. The rabbits received four immunisations at 2 week intervals by subcutaneous injection. Sera were collected after the fourth injection. The diluted antiserum (1/1,000) strongly reacted with purified antigen on Western blot analysis.
The IgG of normal rabbit serum and of immunized rabbit serum was purified as follows. Pooled serum (15 ml) was mixed with the same volume of 80% saturated ammonium sulphate (SAS) in 0.01 M phosphate buffered saline (PBS) (pH 7.0) (40% SAS-serum). The precipitate was then collected and dissolved in 2 ml of PBS. Ion-exchange chromatography was carried out on DEAE-cellulose (DE52, Whatman) column (1x15 cm; bed volume approximately 10 ml) equilibrated with 0.0175 M PB (pH 6.8). The 40% SAS-serum was dialysed against the starting buffer and loaded onto the column. The IgG was eluted by 0.0175 M PB, the elutants were collected and the absorbance of the fractions was measured at 280 nm.
SDS PAGE and western blot analysis
Fresh testicular samples were homogenised with physiological saline solution for eel (Miura et al., 1991a) at 4°C. The testicular homogenate was mixed with an equal volume of nonreducing (125 mM Tris-HCl, 4% (w/v) SDS, 20% (v/v) glycerol and 0.05% (w/v) Bromophenol Blue) or reducing sample buffer [nonreducing sample buffer with 10% (v/v) 2-mercaptoethanol]. The mixture was heated in a boiling water bath for 5 minutes, centrifuged at 9000 g for 5 minutes, and then the supernatant of the tissue extracts was collected. Samples were separated using SDS-PAGE on 10% gels. The separated proteins were transferred to polyvinylidene difluoride membranes (Millipore). After blotting, the membranes were incubated and shaken for 30 minutes in 5% skimmed milk in 20 mM Tris-HCl (pH 7.5) containing 0.5 M NaCl (TBS) to block nonspecific binding sites. The blocked membranes were immersed overnight in 5% skimmed milk containing the primary antibody against eSRS21 diluted to 1:1000. After washing twice with TBS containing 0.025% Tween 20 (TTBS) and then with TBS, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (BioRad) diluted to 1:1000 in TBS for 2 hours at room temperature. After washing, HRP activity was visualised using a freshly prepared solution of 0.06% 4-chloro-1-napthol in TBS containing 0.06% H2O2. To demonstrate the specificity of eSRS 21 antibody, the same procedures of Western blot analysis were carried out without primary antibody as a negative control.
Immunoprecipitation
Testes (100 mg) from intact eels were homogenised with an equal volume of 0.25 M sucrose containing 10 µg/ml leupeptin and 100 mM phenylmethanesulphonyl fluoride. After centrifugation at 9000 g for 10 minutes, the supernatant was incubated with 10 volumes of immunoprecipitation buffer (10 mM Tris-HCl, 0.1 M NaCl, 1 mM EDTA, 1% Nonidet P-40, pH 7.5) containing 50 µl of anti-eSRS21 antibody. After overnight incubation at 4°C, the immunocomplex was absorbed with 50 µl of protein A-Sepharose (Pharmacia) for 1 hour at 37°C. The beads were washed with TTBS by centrifugation at 1000 g for 10 minutes and treated with fivefold more concentrated SDS sample buffer. As a negative control, the same procedure was carried out without testicular samples. Proteins were separated by 10% acrylamide gels and blotted onto PVDF membranes, which were immunostained with an anti-eSRS21 antibody.
Production of recombinant eSRS21
Recombinant eSRS21 using CHO DHFR cells was produced by using the methods of Murata et al. (Murata et al., 1988). The eSRS21 cDNA was inserted into pSD(X) containing pSV2dhfr (Murata et al., 1988
) in the correct orientation between the SV40 early promoter and the poly(A)+ signal. We designated this expression vector as pSD(X)/esrs21c19. pSD(X)/esrs21c19 (10 µg) was transfected into CHO DHFR cells by electropolation, according to the electroporator manual (BioRad). Transformants were selected after 2 weeks of growth at 37°C in selection medium without ribonucleotide and deoxyribonucleotides (MEM ALPHA medium, Gibco). Initially, transformants were grown in the selection medium with 100 nM methotrexate (MTX). The medium was then changed every 3 days until MTX-resistant transformants appeared, and the concentration of MTX in the medium was gradually increased to 10 µM. Four days before collecting the conditioned medium, the culture medium was replaced without MTX and FCS. The same procedure was carried out using pSD(X) vector alone. The CHO cells were transfected with pSD(X)/eSRS21, and the conditioned medium was assayed by western blot analysis to check production and secretion of the recombinant protein.
Conditioned medium (80 ml) containing eSRS21 recombinant protein was concentrated by ammonium sulphate precipitation at 4°C. The precipitate was redissolved in 3 ml of distilled water and dialysed with distilled water. The dialysed protein concentrate was fractionated by ion exchange chromatography on a CM SepharoseTM Fast Flow column (Pharmacia) using a stepwise gradient of 0 to 1 M sodium chloride. The fraction containing eSRS21 was dialysed against PBS and then applied to a SephadexTM G-25 gel-filtration column (Pharmacia). The eluted fractions contained recombinant eSRS21 as the major protein, which reacted with anti-eSRS21 antibody by western blotting, and a few minor protein contaminants. These partially purified samples were dialysed against physiological saline solution for eel and diluted with Leibovitz L-15 medium supplemented with 0.5% bovine serum albumin fraction V (Sigma) and 10 mM Hepes and adjusted to pH 7.4.
Testicular organ culture techniques
Testicular organ culture techniques were performed as described (Miura et al., 1991b), with minor modifications. Freshly removed eel testes were cut into 1x1x0.5 mm pieces and placed on floats of 1.5% agarose covered with a nitrocellulose membrane in 24-well plastic tissue culture dishes. The agarose floats were substituted with basal medium for 18 hours before the start of culture. Testicular fragments were then cultured in 1 ml of the basal medium with 0, 0.005, 0.05, 0.5 and 5 ng/ml of recombinant eSRS21 and/or 10 ng/ml of 11-ketotestosterone, the concentration that is most effective for inducing spermatogenesis (Miura et al., 1991b
), for 15 days at 20°C in humidified air. The basal culture medium consisted of Leibovitz L-15 medium supplemented with 1.7 mM proline, 0.1 mM asparatic acid, 0.1 mM glutamic acid, 0.5% bovine serum albumin fraction V (Sigma), 1 mg/ml bovine insulin and 10 mM Hepes adjusted to pH 7.4. The medium was changed on day 7.
Testicular germ cell/somatic cell co-culture system with anti-eSRS21 antibody
Testicular germ cell/somatic cell co-culture techniques were performed as described (Miura et al., 1996), with minor modifications. Germ cells and somatic cells containing mainly Sertoli cells were isolated from the testes of five eels by collagenase and dispase treatment. For each eel sample, aliquots of 0.5x106 of these isolated cells were suspended with 1 ml of basal culture medium containing 50 µg of purified anti-eSRS21 IgG. The cells were pelleted by centrifugation at 1000 g for 10 minutes at 20°C. After centrifugation, each pellet was incubated for 24 hours in a microcentrifuge tube (1.5 ml; Greiner) at 20°C. Five pellets were collected and analysed to give an initial control value, and another five pellets were transferred to 24-well culture dishes (Iwaki) and cultured with 1 ml of basal medium containing 50 µg of anti-eSRS21 IgG for 15 days at 20°C in humidified air. For control experiments, 10 pellets were treated with an equal amount of normal rabbit IgG instead of anti-eSRS21 IgG at all the relevant stages, and five of these 10 control samples were cultured with 11-ketotestosterone for 15 days as a positive control. The medium was not changed during the culture period.
Detection of proliferating germ cells
To detect the proliferating cells, labelling with 5-bromo-2-deoxyuridine (BrdU) was carried out according to the manufacturers instructions (Amersham Pharmacia Biotech), with minor modifications. Testicular fragments or pellets of testicular germ cell/somatic cells were incubated with BrdU (1 µl/well) for the last 12 hours of culture. After culture, samples were fixed in Bouins solution, and 5 µm paraffin wax-embedded sections were cut and stained immunohistochemically. Sections were then counterstained with Delafields Haematoxylin. The number of immunolabelled germ cells was counted and expressed as a percentage of the total number of germ cells.
Statistics
Data analysis was carried out by the Sceirer, Ray, and Hare extension of the Kruskal-Wallis test (a two-way ANOVA design for ranked data), followed by the post-hoc Benferroni adjustment. A value of P<0.05 per number of comparisons was considered to be significant.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The screening of approximately 2x106 plaques from an intact eel testicular cDNA library yielded positive clones for eSRS21, and the clone with the longest insert was subjected to sequence analysis.
Characterisation of eSRS21
esrs21c19, the longest cDNA clone of eSRS21, has a 2017 bp insert (DDBJ/EMBL/GenBank Accession Number, AB074569). The sequence contains a long open reading frame encoding 614 amino acids (Fig. 1). Three potential N-linked glycosylation sites are located at Asn (77) to Ala (80), Asn (144) to Gly (147) and Asn (398) to Ala (401). The N-terminal regions of this clone are rich in hydrophobic amino acid residues, which is characteristic of signal peptides. According to the (3, 1) rule (von Heijne, 1984), in combination with the signal peptidase cleavage pattern (von Heijne, 1986
), there is likely to be a cleavage site for signal peptidase located between Pro (22) and Gln (23).
|
To confirm the existence of the eSRS21 protein, we carried out western blot analysis and immunoprecipitation on immature eel testes using an anti-eSRS21 antibody (Fig. 2). eSRS21 was detected as a band of 60 kDa in western blotting under reducing conditions. Under non-reducing conditions, however, the eSRS21 band shifted to 120 kDa (Fig. 2A). Immunoprecipitation also revealed a 30 kDa band, which was not detected in the negative control (Fig. 2B). However, this band did not appear in western blot analysis (Fig. 2A). We also assayed CHO cells transfected with pSD(X)/esrs21c19 and their conditioned medium by western blot analysis under reducing conditions (Fig. 2C). Although the 30 kDa and 60 kDa bands that react with anti-eSRS21 were detected in the transfected cells, only the 30 kDa band was found in the conditioned medium. This 30 kDa band did not shift to a higher mass under non-reducing conditions (data not shown). By contrast, none of these bands was detected in the mock transformants or their conditioned medium. Although all western blot analyses were carried out without primary antibody against eSRS21 for the negative control, no band could be detected except for the bands of IgG in immunoprecipitation (data not shown).
|
|
|
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
As mentioned above, it is thought that transcription of the gene encoding a key factor regulating spermatogenesis is controlled by 11-KT, a spermatogenesis-inducing steroid, and that this factor is expressed in Sertoli cells in which the receptor for 11-KT is located. In this study, we found that eSRS21 mRNA was expressed in the Sertoli cells of immature eel testis in which the spermatogenesis process is resting. Moreover, eSRS21 gene expression was downregulated not only by hCG injection in vivo, but also by 11-KT treatment in vitro. These findings suggest that eSRS21 fulfils the criteria defined for a key factor that regulates spermatogenesis.
The esrs21c19 clone was isolated from a normal cDNA library constructed from nondigested cDNA fragments inserted into a zapII vector. A homology search of the predicted amino acid sequence showed that eSRS21 shares comparatively high similarity with Müllerian-inhibiting substance (MIS). Furthermore, eSRS21 also has seven conserved cysteine residues in its C-terminal region, a feature of the TGFß superfamily (Massagué, 1990
), and forms dimers in situ as observed by the 120 kDa band in western blots run under non-reducing conditions. These findings indicate that eSRS21 may be the eel homologue of MIS and a member of the TGFß superfamily.
Under reducing conditions, testicular eSRS21 exhibits two forms with different molecular masses: one of 60 kDa and another of 30 kDa. CHO cells transfected with esrs21c19 cDNA also produce these two forms of recombinant protein. However, conditioned medium from the transfected CHO cells contains only the 30 kDa form. Although further investigation is needed, it seems likely that eSRS21 is produced as a 60 kDa protein in Sertoli cells but is secreted as 30 kDa protein after proteolytic processing, similar to the processing that occurs with members of the TGFß superfamily (Massagué, 1990). Although the testicular 30 kDa protein was detected by immunoprecipitation, it was difficult to detect by using western blot analysis. This suggests that the quantity of 30 kDa protein is less than 60 kDa protein in situ condition. There may be some regulational mechanisms in this proteolytic processing from 60 kDa to 30 kDa form.
In general, growth factors belonging to the TGFß superfamily are disulphide-linked homo- or heterodimers (Massagué, 1990). Although the testicular 60 kDa eSRS21 forms a dimer, the 30 kDa secreted recombinant eSRS21 from CHO cells is monomeric. From our results, however, it is not clear whether the testicular 30 kDa eSRS21 is monomeric or dimeric. Although mammalian CHO cells may not faithfully construct teleostean eSRS21, it seems likely that eSRS21 does not need to form a dimer, because its monomeric recombinant retains biological action in eel spermatogenesis
MIS, also called anti-Müllerian hormone (AMH), is a glycoprotein that is expressed early in gonadal differentiation of the mammalian male. MIS was identified and later purified on the basis of its ability to induce regression of primordium of female genitalia primordium, the Müllerian duct, in mammalian embryos (Balanchard and Josso, 1974). MIS is also produced by Sertoli cells of the fetal and adult testis and by ovarian granulose cells after birth (Balanchard and Josso, 1974
; Vigier et al., 1984
). In ovary, MIS blocks meiosis (Takahashi et al., 1986
), leading to a loss of germ cells (Vigier et al., 1987
; Behringer et al., 1990
), and inhibits the transcription of aromatase (Vigier et al., 1989
) and LH receptor (di Clemente et al., 1994
). MIS also affects the function of the adult testis by blocking the differentiation of mesenchymal into Leydig cells (Behringer et al., 1990
; Behringer et al., 1994
; Mishina et al., 1996
) and by decreasing the expression of steroidogenic enzymes (Racine et al., 1998
; Rouiller-Fabre et al., 1998
; Teixeria et al., 1999
); however, MIS does not affect germ cell development in mammalian males. Thus, MIS is a growth factor with multiple functions in mammalian reproduction. Because teleosts do not have a Müllerian duct (Hoar, 1957
), we propose that eSRS21 may share similar functions with MIS except for regression of the Müllerian duct in male eels.
Using recombinant eSRS21 protein produced from a CHO expression system, we investigated the effect of eSRS21 on 11-KT-induced in vitro spermatogenesis. Adding recombinant eSRS21 to culture media suppressed the spermatogonial proliferation induced by 11-KT, with peak suppression occurring at 500 pg/ml. Thus, eSRS21 is able to suppress 11-KT-induced spermatogenesis. Furthermore, removing eSRS21 secreted from Sertoli cells using an anti-eSRS21 antibody induced spermatogonial proliferation in a testicular germ cell/somatic cell co-culture system. This indicates that under normal conditions, eSRS21 inhibits the start of spermatogenesis in Japanese eel. In mammal, MIS inhibits the growth of ovarian epithelial cells, ovarian cancer cells and breast cancer cells (Ha et al., 2000; Segev et al., 2000
). Taken together, these observations suggest that MIS and its homologous protein, eSRS21, have a role in suppressing cell proliferation.
It has been reported that MIS affects breast cancer cells through an NFB-mediated pathway, which leads to the inhibition of cell growth (Segev et al., 2000
). When MIS suppresses androgen synthesis in Leydig cell in mammalian fetal testis, however, its signal transduction directly mediates downregulation of the mRNA expression of cytochrome P450c17
hydroxylase/C17-20 lyase. (Teixerira et al., 1999
). In future, it will be necessary to establish whether eSRS21 inhibits spermatogonial proliferation by directly affecting germ cells, or by mediating its actions through either the production of steroid hormones other than 11-KT or via the production of growth factors such as BMP8B and activin B, which are known to affect spermatogonial proliferation (Zhao et al., 1996
; Miura et al., 1995
).
We propose that eSRS21 should be called not MIS but spermatogenesis-preventing substance (SPS) for the following six reasons: (1) eSRS21 is expressed in the Sertoli cells of immature eel before the initiation of spermatogenesis; (2) the initiation of spermatogonial proliferation corresponds with the disappearance of eSRS21 expression; (3) eSRS21 expression is downregulated by 11-KT, which is a spermatogenesis-inducing steroid; (4) recombinant eSRS21 prevents spermatogenesis induced by 11-KT treatment an in vitro organ culture; (5) removing naturally occurring eSRS21 protein from testis using a specific antibody induces the initiation of spermatogenesis in an in vitro germ cell/somatic cell co-culture; and (6) teleosts do not have a Müllerian duct.
Although the molecules involved have not been identified, evidence for the existence of hormones or factors that suppress spermatogenesis, especially meiosis, has been shown for polychaeta and mammalia (Bertout, 1984; Gondos et al., 1996
; Hayashi et al., 2000
). We suggest that eSRS21/SPS may be one of these factors in Japanese eel.
As mentioned above, in fresh-water conditions eel spermatogenesis arrests at an immature stage prior to initiation of spermatogonial proliferation. This immature stage seems to be maintained by the expression of SPS in eel Sertoli cells in fresh-water conditions. When eels downmigrate to the ocean, spermatogenesis resumes and progresses to maturation (Larsen and Dufour, 1993). We propose that during eel migration, spermatogenesis is resumed through a suppression of SPS expression caused by an increase in 11-ketotestosterone, which is induced by gonadotropin stimulation.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Abe, S.-I. (1987). Differentiation of spermatogenetic cells from vertebrates in vitro. Int. Rev. Cytol. 109, 159-209.[Medline]
Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D. and Brinster, R. L. (1990). Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature 345, 167-170.[Medline]
Behringer, R. R., Finegold, M. J. and Cate, R. L. (1994). Müllerian-inhibiting substance function during mammalian sexual development. Cell 79, 415-425.[Medline]
Bertout, M. (1984). Spermatogenesis in Nereis as a model for the study of endocrine control. Fortschr. Zool. 29, 115-122.
Blanchard, M. and Josso, N. (1974). Source of anti-Müllerian hormone synthesized by the fetal testis: Müllerian inhibiting activity of fetal bovine Sertoli cells in culture. Pediatr. Res. 8, 968-971.[Medline]
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J. and Chow, E. P. (1986). Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685-698.[Medline]
Clermont, Y. (1972). Kinetics of spermatogenesis in mammals. Seminiferous epithelium cycle and spermatogonial renewal. Int. Rev. Cytol. 70, 27-100.
di Clemente, N., Goxe, B., Remy, J. J., Cate, R. L., Josso, N., Vigier, B. and Salesse, R. (1994). Inhibitory effect of AMH upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immture ovaries. Endocrine 2, 553-558.
Eusèbe, D., di Clemente, N., Rey, R., Pieau, C., Vigier, B., Josso, N. and Picard, J. (1996). Cloning and expression of the chick anti-Müllerian hormone gene. J. Biol. Chem. 271, 4798-4804.
Gondos, B., Byskov, A. G. and Hansen, J. L. (1996). Regultion of the onset of meiosis in the developing testis. Ann. Clin. Lab. Sci. 26, 421-425.[Abstract]
Ha, T. U., Segev, D. L., Barbie, D., Masiakos, P. T., Tran, T. T., Dombkowski, D., Glander, M., Clarke, T. R., Lorenzo, H. K., Donahoe, P. K. et al. (2000). Müllerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism. J. Biol. Chem. 275, 37101-37109.
Hayashi, T., Kageyama, Y., Ishizaka, K., Kihara, K. and Oshima, H. (2000). Sexual dimorphism in the regulation of meiotic process in the rabbit. Biol. Reprod. 62, 1722-1727.
Herrin, D. L. and Schmidt, G. W. (1988). Rapid, reversible staining of northern blots prior to hybridization. BioTechniques 6, 196-197.[Medline]
Hoar, W. S. (1957). The gonads and reproduction. In The Physiology of Fishes, Vol. I (ed. M. E. Brown), pp. 287-321. New York: Academic Press.
Ikeuchi, T., Todo, T., Kobayashi, T. and Nagahama, Y. (2001). Two subtypes of androgen and progestogen receptors in fish testes. Comp. Biochem. Physiol. 129B, 449-455.
Larsen, L. O. and Dufour, S. (1993). Growth, reproduction and death in lampreys and eels. In Fish Ecophsiology (ed. J. C. Rankin and F. B. Jensen), pp. 72-104. London: Chapman & Hall.
Massagué, J. (1990). The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 597-641.
Mishina, Y., Rey, R., Finegold, M. J., Matzuk, M. M., Josso, N., Cate, R. L. and Behringer, R. R. (1996). Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway. Genes Dev. 10, 2577-2587.[Abstract]
Miura, C., Miura, T., Yamashita, M., Yamauchi, K. and Nagahama, Y. (1996). Hormonal induction of all stages of spermatogenesis in germ-somatic cell coculture from immature Japanese eel testis. Dev. Growth Differ. 38, 257-262.
Miura, T., Kudo, N., Miura, C., Yamauchi, K. and Nagahama, Y. (1998). Two testicular cDNA clones suppressed by gonadotropin stimulation exhibit ZP- and ZP3- like structures in Japanese eel. Mol. Reprod. Dev. 51, 235-242.[Medline]
Miura, T., Miura, C., Yamauchi, K. and Nagahama, Y. (1995). Human recombinant activin induces proliferation of spermatogonia in vitro in the Japanese eel Anguilla japonica. Fisheries Sci. 63, 434-437.
Miura, T., Yamauchi, K., Nagahama, Y. and Takahashi, H. (1991a). Induction of spermatogenesis in male Japanese eel, Anguilla japonica, by a single injection of human chorionic gonadotropin. Zool. Sci. 8, 63-73.
Miura, T., Yamauchi, K., Takahashi, H. and Nagahama, Y. (1991b). Hormonal induction of all stages of spermatogenesis in vitro in the male Japanese eel (Anguilla japonica). Proc. Natl. Acad. Sci. USA 88, 5774-5778.[Abstract]
Miura, T., Yamauchi, K., Takahashi, H. and Nagahama, Y. (1991c). Human chorionic gonadotropin induces all stages of spermatogensis in vitro in the male Japanese eel (Anguilla japonica). Dev. Biol. 146, 258-262.[Medline]
Münsterberg, A. and Lovell-Badge, R. (1991). Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 113, 613-624.[Abstract]
Murata, M., Eto, Y., Shibai, H., Sakai, M. and Muramatu, M. (1988). Erythroid differentiation factor is encoded by the same mRNA as that of inhibin ßA chain. Proc. Natl. Acad. Sci. USA 85, 2434-2438.[Abstract]
Nagahama, Y. (1994). Endocrine regulation of gametogenesis in fish. Int. J. Dev. Biol. 38, 217-229.[Medline]
Niwa, H., Harrison, L. C., DeAizpura, T. J. and Cram, D. S. (1997). Identification of pancreatic ß cell-related genes by representational difference analysis. Endocrinorogy 138, 1419-1426.
Racine, C., Rey, R., Forest, M. G., Louis, F. and Ferre, A. (1998). Receptors for anti-Müllerian hormone on Leydig cells areresponsible for its effects on steroidgenesis and celldifferentiation. Proc. Natl. Acad. Sci. USA 95, 594-599.
Rouiller-Fabre, V., Carmona, S., Abou-Merhi, R., Cate, R. L., Hebert, R. and Vigier, B. (1998). Effect of anti-Müllerian hormone on Sertoli and Leydig cell functions in fetal and immature rats. Endocrinology 139, 1213-1220.
Segev, D. L., Ha, T. U., Tran, T. T., Kenneally, M., Harkin, P., Jung, M., MacLaughlin, D. T., Donahoe, P. K. and Maheswaran, S. (2000). Müllerian inhibiting substance inhibits breast cancer cell growth through an NF B-mediated pathway. J. Biol. Chem. 275, 28371-28379.
Takahashi, M., Koide, S. S. and Donahoe, P. K. (1986). Müllerian inhibiting substance as oocyte meiosis inhibitor. Mol. Cell. Endocrinol. 47, 225-234.[Medline]
Teixeira, J., Fynn-Thompson, E., Payne, A. H. and Donahoe, P. K. (1999). Müllerian-inhibiting substance regulates androgen synthesis at transcriptional level. Endocrinology 140, 4732-4738.
Thompson, J. D., Higgins, D. G. and Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic acids Res. 22, 4673-4680.[Abstract]
Vigier, B., Picard, J. Y., Campargue, J., Forest, M. G., Heyman, Y. and Josso, N. (1984). Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114, 1315-1320.[Abstract]
Vigier, B., Wang, Z., Magre, S., Tran, D. and Josso, N. (1987). Purified bovine AMH induces a chracteristic freemartin effect in fetal rat prospective ovaries exposed to it in vitro. Development 100, 43-55.[Abstract]
Vigier, B., Forest, M. G., Eychenne, B., Bezard, J., Garrigou, O., Robel, P. and Josso, N. (1989). Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries. Proc. Natl. Acad. Sci. USA 86, 3684-3688.[Abstract]
von Heijne, G. (1984). How signal sequences maintain cleavage specificity. J. Mol. Biol. 173, 243-251.[Medline]
von Heijne, G. (1986). A new method for predicting signal sequence cleavage site. Nucleic Acids Res. 14, 4683-4690.[Abstract]
Yamamoto, K., Hiroi, O., Hirano, T. and Morioka, T. (1972). Artificial maturation of cultivated male Japanese eel by Synahorin injection. Bull. Jpn. Soc. Sci. Fish. 38, 1083-1090.
Zhao, G. Q., Deng, K., Labosky, P. A., Liaw, L. and Hogan, B. L. M. (1996). The gene encoding bone morphogenetic protein 8B (BMP8B) is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev. 10, 1657-1669.[Abstract]